retatrutide clinical study Results: 28.3% Weight Loss Data retatrutide clinical trials phase 2

In a sensitivity analysis excluding the SELECT trial, which was the only study enrolling pre-diabetic participants, the reduction in MACE remained consistent (HR (95% CI): 0.87(0.820.93)

Wium-Andersen IK, Wium-Andersen MK, Fink-Jensen A, et al

HGH therapy can potentially accelerate the healing process in certain conditions

Beyond conventional liver function markers such as aspartate transaminase (AST) and alanine aminotransferase (ALT), several other liver-derived indices exhibit characteristic changes concurrent with clinical and pathological progression of AD [31]

This makes it useful beyond just skin it may modulate systemic inflammation